Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedThe Record History now shows a new revision entry labeled v3.5.4, replacing the previous v3.5.3. This reflects an update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedUpdated the website interface revision label from v3.5.2 to v3.5.3 on the record history page.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 in the study history.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.0 was added to the record history and Revision: v3.4.3 was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedA new revision entry v3.4.3 was added to the record history. The previous entry v3.4.2 was removed from the list.SummaryDifference0.2%

- Check94 days agoChange DetectedA new revision label, Revision: v3.4.2, was added to the record history, and a government funding notice (and the prior v3.4.1 entry) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.